Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL352075 | 0.75 | CA12 (0.33) | CA12CA1CA9TSHRKMT2A | |
| Acetic Acid SCHEMBL21834859 | 0.74 | FFAR3 (0.39) | FFAR3LCKFYNCA12CA1 | |
| Acetic Acid SCHEMBL482738 | 0.74 | FFAR3 (0.39) | FFAR3LCKFYNCA12CA1 | |
| Succinchlorimide SCHEMBL27913334 | 0.72 | FFAR3 (0.37) | FFAR3LCKFYNCA12CA1 | |
| Acetic Acid SCHEMBL3939404 | 0.72 | FFAR3 (0.37) | FFAR3LCKFYNCA12CA1 | |
| SCHEMBL5408573 | 0.70 | CA12 (0.33) | CA12CA1CA9 | |
| SCHEMBL8768383 | 0.68 | CA12 (0.32) | CA12CA1CA9 | |
| Acetic Acid SCHEMBL27911516 | 0.68 | — | — | |
| SCHEMBL887169 | 0.65 | NOTUM (0.42) | CA12CA1CA9GLAKMT2A | |
| Acetic Acid SCHEMBL27816213 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017046658-A1 | DERIVATIVES OF AMANITA TOXINS AND THEIR CONJUGATION TO A CELL BINDING MOLECULE | HANGZHOU DAC BIOTECH CO, LTD (CN) | 2017-03-23 | — | — | WO | disclosed |
| US-20100016225-A1 | CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY | TRIMERIS, INC. | 2010-01-21 | — | — | US | disclosed |
| US-7556813-B2 | Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides | TRIMERIS, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1554306-A4 | CONJUGATES COMPRISED OF POLYMER AND HIV GP41-DERIVED PEPTIDES AND THEIR USE IN THERAPY | TRIMERIS INC (US) | 2009-01-21 | — | — | EP | disclosed |
| EP-1554306-A2 | CONJUGATES COMPRISED OF POLYMER AND HIV GP41-DERIVED PEPTIDES AND THEIR USE IN THERAPY | Trimeris, Inc. (US) | 2005-07-20 | — | — | EP | disclosed |
| US-20040122214-A1 | Conjugates comprised of polymer and HIV gp41-derived peptides and their use in therapy | TRIMERIS, INC. | 2004-06-24 | — | — | US | disclosed |
| WO-2004029073-A2 | CONJUGATES COMPRISED OF POLYMER AND HIV GP41-DERIVED PEPTIDES AND THEIR USE IN THERAPY | TRIMERIS, INC. (US) | 2004-04-08 | — | — | WO | disclosed |